story of the week
Molecular Biomarkers Predictive of Resistance to CDK4/6 Inhibition
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JCO Precision Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Systematic Review of Molecular Biomarkers Predictive of Resistance to CDK4/6 Inhibition in Metastatic Breast Cancer
JCO Precis Oncol 2022 Jan 01;6(01)e2100002, US Asghar, R Kanani, R Roylance, S MittnachtFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.